The safety and efficacy of CO2 laser in the treatment of stress urinary incontinence

2019 ◽  
Vol 31 (8) ◽  
pp. 1691-1696 ◽  
Author(s):  
Hanin Dabaja ◽  
Roy Lauterbach ◽  
Emad Matanes ◽  
Ilan Gruenwald ◽  
Lior Lowenstein
Author(s):  
Gamal Ghoniem ◽  
Bilal Farhan ◽  
Mashrin Lira Chowdhury ◽  
Yanjun Chen

Abstract Introduction and hypothesis This study aimed to report 3-year completed follow-up of the safety and efficacy of Macroplastique® (MPQ) in women with stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). Methods This is a retrospective analysis of all women who completed 3-year follow-up post-MPQ injection(s) at ten medical centers. We used the ROSE registry data report of Macroplastique® [Macroplastique® Real-time Observation of Safety and Effectiveness (ROSE) registry P040050/PAS001 on 2017]. Subjective incontinence outcome and adverse effects were assessed. Results The study included all patients (n = 70) who completed 3-year follow-up after the last MPQ injection. Twenty-four of 70 (34%) patients had two injections; 21/70 (30%) patients reported Stamey grade 0 and 28/70 (40%) reported Stamey grade 1. The overall patient satisfaction was 68% who completed 3-year follow-up. The composite success rate (I-QoL, PGI-S, and Stamey grade improvement) was 51.4%. No serious adverse events (AE) were reported within the completed 3-year follow-up. Conclusions MPQ was found to be safe and efficacious for the treatment of SUI secondary to ISD in women. The overall high satisfaction rate was sustained from baseline to 3 years post-injection. Most complications were minor and transient without sequelae.


2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Omar Felipe Duenas-Garcia ◽  
Robert Edward Shapiro ◽  
Peter Gaccione

2011 ◽  
Vol 186 (6) ◽  
pp. 2310-2315 ◽  
Author(s):  
Douglas G. Tincello ◽  
Theunis Botha ◽  
Douglas Grier ◽  
Peter Jones ◽  
Dhinagar Subramanian ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document